A61K 31/727
Heparin
Official title: Heparin; Heparan
A61K31/727 (Heparin) appears on 772 US grants and 1,346 published applications in this corpus.
Search patents in A61K- Granted patents
- 772
- Published applications
- 1,346
- Assignees
- 638
- Inventors
- 2,106
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 3 | 0 |
| 1997 | 14 | 0 |
| 1998 | 19 | 0 |
| 1999 | 14 | 0 |
| 2000 | 20 | 0 |
| 2001 | 14 | 7 |
| 2002 | 19 | 43 |
| 2003 | 17 | 49 |
| 2004 | 16 | 44 |
| 2005 | 12 | 61 |
| 2006 | 19 | 73 |
| 2007 | 15 | 78 |
| 2008 | 20 | 40 |
| 2009 | 18 | 33 |
| 2010 | 22 | 45 |
| 2011 | 29 | 53 |
| 2012 | 25 | 53 |
| 2013 | 32 | 55 |
| 2014 | 51 | 73 |
| 2015 | 30 | 65 |
| 2016 | 53 | 70 |
| 2017 | 34 | 53 |
| 2018 | 29 | 48 |
| 2019 | 38 | 50 |
| 2020 | 34 | 50 |
| 2021 | 29 | 63 |
| 2022 | 27 | 62 |
| 2023 | 39 | 62 |
| 2024 | 19 | 46 |
| 2025 | 30 | 42 |
| 2026 | 18 | 28 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fish swim bladder-derived heparin-like mucopolysaccharide and methods of making and using the same22 Sep 2026US 12,740,998 B2Guangdong Ocean University
- Biomarkers for the diagnosis of atrial fibrillation cause of stroke25 Aug 2026US 12,716,097 B2Ischemia Care LLC
- Methods for treating intracranial hemorrhage and assessing efficacy21 Jul 2026US 12,685,763 B2Alexion Pharmaceuticals, Inc.
- Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol14 Jul 2026US 12,678,490 B2Eli Lilly and Company
- CXCL8 inhibitors for use in the treatment of COVID-1926 May 2026US 12,636,268 B2Dompé Farmaceutici S.P.A.
- Novel glycan compounds for age-related macular degeneration8 Oct 2026US 2026/0306530 A1The Regents of the University of California
- Corneal disorder treatment agent10 Sep 2026US 2026/0263506 A1M's Science Corporation
- Methods, compositions, and devices for drug or live cell microarrays27 Aug 2026US 2026/0248746 A1Pathak Holdings LLC
- Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions20 Aug 2026US 2026/0240898 A1Adora Life Science, Inc.
- Repair and/or reconstruction of invertebral discs20 Aug 2026US 2026/0240918 A1Mesoblast, Inc.
Most cited
By later US patents
- Method for manufacturing a porous ceramic scaffold having an organic/inorganic hybrid coating layer containing a bioactive factor777US 8,734,831 B2Snu R&Db Foundation · 2014
- Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like367US 6,387,379 B1University of Florida · 2002
- Polymer compositions containing bioactive agents and methods for their use299US 6,770,729 B2Medtronic MiniMed, Inc. · 2004
- Coatings for medical devices285US 6,746,773 B2Ethicon, Inc. · 2004
- Amphiphilic polysaccharide derivatives221US 6,245,753 B1Mediplex Corporation, Korea · 2001